[HTML][HTML] Bioactives from mushroom: health attributes and food industry applications
It is well-known that the utilization of mushrooms as therapeutic agents is not new. Over the
past years, they have been used by local individuals as food, as well as medicines …
past years, they have been used by local individuals as food, as well as medicines …
Worldwide control and management of Chagas disease in a new era of globalization: a close look at congenital Trypanosoma cruzi infection
A Abras, C Ballart, A Fernández-Arévalo… - Clinical microbiology …, 2022 - Am Soc Microbiol
Population movements have turned Chagas disease (CD) into a global public health
problem. Despite the successful implementation of subregional initiatives to control vectorial …
problem. Despite the successful implementation of subregional initiatives to control vectorial …
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial
CA Morillo, H Waskin, S Sosa-Estani… - Journal of the American …, 2017 - jacc.org
Background: Benznidazole is recommended for treatment of Chagas infection. Effects of
combination therapy with benznidazole and posaconazole have not been tested in …
combination therapy with benznidazole and posaconazole have not been tested in …
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review
I Beltran-Hortelano, V Alcolea, M Font… - European journal of …, 2020 - Elsevier
The haemoflagellate protozoan Trypanosoma cruzi (T. cruzi) is the causative agent of
Chagas disease (CD), a potentially life-threatening disease. Little by little, remarkable …
Chagas disease (CD), a potentially life-threatening disease. Little by little, remarkable …
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review
Chagas disease, leishmaniasis and schistosomiasis are neglected diseases (NDs) and are
a considerable global challenge. Despite the huge number of people infected, NDs do not …
a considerable global challenge. Despite the huge number of people infected, NDs do not …
The current drug discovery landscape for trypanosomiasis and leishmaniasis: Challenges and strategies to identify drug targets
F Altamura, R Rajesh, CMC Catta‐Preta… - Drug development …, 2022 - Wiley Online Library
Human trypanosomiasis and leishmaniasis are vector‐borne neglected tropical diseases
caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp …
caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp …
[HTML][HTML] Treatment of Chagas disease in the United States
S Meymandi, S Hernandez, S Park… - … treatment options in …, 2018 - Springer
Abstract Purpose of Review Chagas disease (CD) is endemic to much of Latin America, but
also present in the United States (US). Following a lengthy asymptomatic period, CD …
also present in the United States (US). Following a lengthy asymptomatic period, CD …
[HTML][HTML] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease
I Beltran-Hortelano, V Alcolea, M Font… - Bioorganic & medicinal …, 2022 - Elsevier
Chagas disease (CD) is a centenarian neglected parasitosis caused by the protozoan
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …
Trypanosoma cruzi (T. cruzi). Despite the continuous efforts of many organizations and …
Nitriles: an attractive approach to the development of covalent inhibitors
Nitriles have broad applications in medicinal chemistry, with more than 60 small molecule
drugs on the market containing the cyano functional group. In addition to the well-known …
drugs on the market containing the cyano functional group. In addition to the well-known …
Artemisinin and its derivatives in treating protozoan infections beyond malaria
Parasitic protozoan diseases continue to rank among the world's greatest global health
problems, which are also common among poor populations. Currently available drugs for …
problems, which are also common among poor populations. Currently available drugs for …